Children's medicine imports to be fast-tracked
Updated: 2016-06-03 07:27
By Yang Wanli(China Daily)
|
|||||||||
Some children's drugs that have been used in Hong Kong, Macao and Taiwan for years will be put on a fast track for importation, China's top health authority said on Wednesday.
The National Health and Family Planning Commission released a list of 32 drugs to be expedited. The medications are used to treat conditions ranging from cardiovascular disease to endocrine, blood and nervous system disorders.
Most of the drugs have passed clinical tests and been used for years in the three areas, but they have not been available to doctors and patients on the Chinese mainland. Under current rules, approval to import such drugs requires clinical test data collected on the mainland.
"Health authorities have always been concerned over ethical issues and fears of harming children, especially babies," said Zhang Yiran, marketing manager of the China office of pharmaceutical giant Pfizer.
According to the commission, clinical studies in Hong Kong, Macao and Taiwan might be used to support approvals in the future, which means tests on people on the Chinese mainland may not be required.
About 2,200 babies are born in the country every hour. However, drugs for infants and children remain limited. Figures from the China Food and Drug Administration show that more than 170,000 drugs were registered by 2015, but only about 3,000 of those were intended specifically for children.
Fewer options may pose higher risks for children, as many Chinese parents say they prefer to give them adult drugs in smaller doses to treat some mild diseases, such as colds or diarrhea.
"Dosages for children should be carefully measured. Otherwise, the drug can be rendered ineffective or even harmful," said Wang Fei, deputy director of the intensive-care unit at Capital Institute of Pediatrics.
Moreover, she said, drugs for children should have different forms and flavors that help parents administer them more easily.
Beyond the concerns about clinical testing on the Chinese mainland, children's drugs usually come with lower profit margins because of their relatively low dosages, Wang said.
"This new policy helps guide drug companies on new children's drug research," she said.
- Swiss declare Alps tamed as Gotthard rail tunnel opens
- China urges Japan to properly settle Chinese forced laborers issue
- Searching for remains of Dead Sea Scrolls
- China-US relations shouldn't be hijacked by S. China Sea issue
- To cool you off: The fountain in Washington Square Park
- Americans warned about terror risk this summer
- Performers wanted for Shanghai Disney park
- New law protects ancient villages in Southwest China's Lhasa
- Kids with HIV in Shanxi's Red Ribbon School
- Heavy rain turns Wuhan into 'seaside' city
- Photos: Little royals on the Children's Day
- Pure love: Chinese 'little prince'and his fox
- Then and now: Recreating that child-like smile
- Young teacher's heartfelt love for the students
Most Viewed
Editor's Picks
Anti-graft campaign targets poverty relief |
Cherry blossom signal arrival of spring |
In pictures: Destroying fake and shoddy products |
China's southernmost city to plant 500,000 trees |
Cavers make rare finds in Guangxi expedition |
Cutting hair for Longtaitou Festival |
Today's Top News
Chinese State Councilor Yang Jiechi to meet Kerry
Chinese stocks surge on back of MSCI rumors
Liang avoids jail in shooting death
China's finance minister addresses ratings downgrade
Duke alumni visit Chinese Embassy
Marriott unlikely to top Anbang offer for Starwood: Observers
Chinese biopharma debuts on Nasdaq
What ends Jeb Bush's White House hopes
US Weekly
Geared to go |
The place to be |